GNA Biosolutions completes € 6 million financing round
Prepares for market entry with fast diagnostic instruments for hospital bugs
03-Jul-2015 -
GNA Biosolutions GmbH (GNA), a manufacturer of ultrafast pathogen diagnostic instruments, will receive fresh capital of € 6 million in a series B financing round. Founded in 2010, GNA welcomes new investors Robert Bosch Venture Capital (RBVC), SHS Gesellschaft für Beteiligungsmanagement GmbH, ...
diagnostics
molecular diagnostics
pathogen detection
+1